Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

SUPPLY of LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)

Awarded
12481254Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Health Agency is awarding a sole-source contract to Novartis Pharmaceuticals Corporation for the supply of Lutathera and Pluvicto. These radioligand therapies are essential for targeted treatment of specific prostate cancers within the Nuclear Medicine Division of the Department of Radiology at Walter Reed National Military Medical Center. The procurement is designated as a sole-source award because Novartis is the only provider of Pluvicto, making this approach necessary to ensure continuity of patient care and the seamless delivery of critical medical supplies. The performance of this contract will take place in Bethesda, Maryland, under solicitation number 12481254.

General Info

Defense Health Agency sole-source contract with Novartis for Lutathera and Pluvicto cancer therapies.

Contract Value

$480,119.64

NAICS

N/A

Place of Performance

Bethesda, MD, 20889, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
ContactsNo contacts available
OfficeFALLS CHURCH, VA, 22042, USA
Office AddressFALLS CHURCH, VA, 22042, USA
ContactsNo contact information available

Full Description

Show more

Clinical Utility: It is used for targeted radioligand therapy for specific types of prostate cancer within the Nuclear Medicine Division of the Department of Radiology at WRNMMC. Novartis Pharmaceuticals Corporation is the sole source for Pluvicto. Therefore, the recommended course of action is to award a contract directly to Novartis. This approach is deemed to be in the government's best interest to ensure the seamless delivery of these critical supplies and maintain continuity of patient care at WRNMMC. The acquisition will be treated as a sole-source procurement.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 541512
New
Federal
Defense Health Agency (DHA), Program Acquisition Executive, Digital Medical Solutions (PAE DMS), Enterprise Intelligence & Data Solutions (EIDS) Program Management Office (PMO), Data Exchange Services Operations, Modernization, and Development
Solicitation # HT003826SC005-AOI0002
The Defense Health Agency (DHA), through the Enterprise Information and Data Solutions (EIDS) Program Management Office, is seeking commercial solutions for the operations, modernization, and development of the Data Exchange Platform (DxP). This platform is critical for military health readiness and patient care, facilitating secure, standards-based interoperability and real-time clinical data exchange between the DHA, Department of Veterans Affairs, and other federal healthcare partners. The primary objective is to maintain 24x7 operational availability for legacy systems, including Data Exchange Services, the Clinical Health Data Repository, and the Access Control Services Data Access Layer, while transitioning these services toward a cloud-native, API-driven, and AI/ML-ready architecture utilizing containerized RESTful microservices. This opportunity is published as Area of Interest (AOI) #02 under Commercial Solutions Opening HT003826SC005. The government will utilize a multi-phase assessment process, beginning with a Phase I written technical solution brief, to determine the most appropriate acquisition pathway, which may include a FAR-based contract or a prototype other transaction agreement. The anticipated period of performance includes a 12-month base period with subsequent option periods based on milestone completion. Performance will be conducted at contractor facilities with remote work authorized. Technical requirements emphasize strict adherence to DoD Instruction 8510.01 (RMF), Zero Trust frameworks, and DHA cloud security rules. All contractor personnel must be U.S. citizens with appropriate security clearances (Tier 1, 2, or 3). Interested vendors must submit Phase I responses, including a technical solution brief, a draft SOO crosswalk, a proposed performance-based work statement, and an organizational conflict of interest mitigation plan, to Lacey Lockard by October 28, 2026, at 1400 Eastern Time. Technical and administrative questions are due by October 14, 2026.
Computer Systems Design Services

POSTED

1 day ago

DEADLINE

in 20 days
View Details
NAICS: 811210
New
Federal
Steris Sterilizer Maintenance/Service at Offutt AFB, NE
Solicitation # HT940726Q0001
The Defense Health Agency Contracting Activity Central Division is soliciting quotations for a single-award, Firm-Fixed-Price commercial service contract to provide comprehensive maintenance and repair services for Government-owned Steris sterilization and washer equipment. Located at the 55th Medical Group, Ehrling Bergquist Clinic at Offutt Air Force Base, Nebraska, the scope of work includes scheduled preventive maintenance, safety inspections, calibrations, annual chamber cleanings, and unscheduled emergency repairs. Covered equipment consists of three Steris AMSCO 400 Steam Sterilizers, one Steris Reliance Vision Single Chamber Washer Disinfector, two Steris AMSCO 7052HP Single Chamber Washer Disinfectors, and two Steris IWECO5 Ultrasonic Instrument Washers. All services must be performed by certified technicians using genuine Original Equipment Manufacturer parts and software. This procurement is a 100 percent Total Small Business Set-Aside under NAICS codes 811210 and 811211. The anticipated period of performance includes a 12-month base period, four 12-month option periods, and a potential six-month extension, running from November 1, 2026, through April 30, 2032. Award will be determined using the Lowest Price Technically Acceptable method, evaluating the total price across the base, all option years, and the extension. Technical acceptability is based on the contractor's personnel qualifications, OEM access, technical resources, and parts capability. Key performance standards include a 4-hour telephone response time, on-site arrival within 48 business hours for unscheduled repairs, and a minimum monthly equipment uptime of 95 percent.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 11 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS